ASLAN Pharmaceuticals Announces Pricing of $12.8 Million Public Offering of American Depositary Shares

    NEXT STORY
    NICE Recommends the Use of gammaCore for the Treatment of Cluster Headache in the NHS
    PREV STORY
    DAWOODI BOHRAS OFFER MUCH-NEEDED SUPPORT TO THE ELDERLY
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    EyePoint Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Progress

    author_avatar
    NASDAQ Market News

    Number of shares and voting rights of Innate Pharma as at february 7, 2017

    NUMBER OF SHARES AND VOTING RIGHTS OF Innate Pharma AS AT FEBRUARY 7, 2017 ...

    author_avatar
    NASDAQ Market News

    Beyondspring Provides Operational Update and Second-Quarter 2018 Financial Results

    - Reported Top Line Positive Efficacy and Safety Data from Phase 2 Study 106 ...

    author_avatar
    NASDAQ Market News